|
 |
European Pharmaceutical Contractor
|
| With India fast becoming a new pharmaceutical frontier, Ed J Brennan at IndiPharm
explains why outsourcing here makes sense in order to achieve lower cost clinical trials
Western pharmaceutical and biotech companies need to
increase productivity, decrease costs and shorten the time-tomarket
for new drugs. The costs of clinical trials needed to gain
regulatory approval represent roughly two-thirds of the typical
billion-dollar cost of developing a single new chemical entity
(NCE). There is, therefore, a critical need for conducting
clinical trials that provide lower cost and faster recruitment
without compromising the quality of the research.
WHY INDIA?
India provides a number of significant advantages as a
destination for clinical trials. It offers a large patient population,
low per-patient trial costs, and a highly qualified professional
medical community (many of them Western-trained), as well as
global quality hospitals and clinical research facilities.
Furthermore, with a highly developed IT and data collection
capability and no language barrier, India has become an
increasingly attractive destination for clinical trials.
THE BACKGROUND
Until recently, there were few clinical trials conducted in India by
Western pharmaceutical and biotech companies, primarily
because of regulatory hurdles. Recognising the significant
advantages that India offers to multinational companies and the
potential benefits of conducting clinical trials in India, the
Government made major changes in 1999 with the amendments
to Schedule Y of the Drugs and Cosmetics Act. These changes
formalised the definition and conduct of clinical trials; specified
the responsibilities of the sponsor, the investigators, and the
Ethics Committees; developed guidelines and procedures for
importing drugs for clinical trials; instituted required compliance
with GCP; specified the requirements for informed consent; and
defined the structure, content and formats of clinical study
reports. In addition, the Indian Government provided increased
protection for intellectual property (IP). |
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Clinical Trial Logistics
17-18 May 2010, London, UK
This year’s conference will provide you with the tools necessary to effectively manage your supply chain and ensure that your trials complete on time and within budget. This conference will also analyse the latest developments in labelling, packaging, inventory management, security, forecasting, partnering and outsourcing.
More info >> |
|
 |
News and Press Releases |
 |
Manufacturers Opting for OPTIMA Performance
Over the past 15 years Optima Control Solutions Ltd (OCS) has developed an unrivalled reputation for designing, building and commissioning high-quality drive control systems and through its sister company, Infoserve365, is also now a UK leader in managed data collection and analysis
More info >> |
|
 |
